[Federal Register: March 24, 2008 (Volume 73, Number 57)]
[Notices]
[Page 15524]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24mr08-70]
[[Page 15524]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Vaccine Safety Working Group
AGENCY: Department of Health and Human Services, Office of the
Secretary.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (DHHS) is hereby
giving notice that the National Vaccine Program Office (NVPO) will
convene a meeting of NVAC's Vaccine Safety Working Group. The meeting
is open to the public.
DATES: The meeting will be held on April 11, 2008, from 9 a.m. to 5
p.m.
ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey
Building, Room 705A; 200 Independence Avenue, SW., Washington, DC
20201.
FOR FURTHER INFORMATION CONTACT: Daniel Salmon, Vaccine Safety
Specialist, National Vaccine Program Office, Department of Health and
Human Services, Room 443-H Hubert H. Humphrey Building, 200
Independence Avenue, SW., Washington, DC 20201; (202) 260-1587 or
daniel.salmon@hhs.gov.
SUPPLEMENTARY INFORMATION: NVPO has responsibility for coordinating and
ensuring collaboration among the many Federal agencies involved in
vaccine and immunization activities. The NVPO provides leadership and
coordination among Federal agencies, as they work together to carry out
the goals of the National Vaccine Plan. The National Vaccine Plan
provides a framework, including goals, objectives, and strategies, for
pursuing the prevention of infectious diseases through immunizations.
NVPO periodically convenes groups to address specific issues and topics
that impact vaccine and immunization.
The Vaccine Safety Working Group has been established to (1)
undertake and coordinate a scientific review of the draft Immunization
Safety Office (Centers for Disease Control and Prevention) research
agenda, and (2) review the current vaccine safety system.
Following the advice of the Institute of Medicine in its report
``Vaccine Safety Research, Data Access and Public Trust'' (February 17,
2005), this meeting of the Working Group is open to the public, noting
that pubic attendance is limited to space available. Individuals must
provide a photo ID for entry into the Humphrey Building. Individuals
who plan to attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
designated contact person. Members of the public will have the
opportunity to provide comments at the meeting. Public comment will be
limited to five minutes per speaker. Any members of the public who wish
to have printed material distributed to meeting participants should
submit materials to the NVPO staff person designated as the contact for
additional information. All materials should be submitted to the
designated point of contact no later than close of business April 9,
2008. Pre-registration is required for both public attendance and
comment. Any individual who wishes to attend the meeting and/or
participate in the public comment session should contact the designated
staff member, Daniel Salmon, by e-mail daniel.salmon@hhs.gov or call
202-690-5566.
Dated: March 18, 2008.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. E8-5892 Filed 3-21-08; 8:45 am]
BILLING CODE 4150-44-P